- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Placebo (sitagliptin)
Total 54296 results
-
Michael A. NauckCompleted
-
TakedaCompletedDiabetes MellitusUnited States, Mexico
-
Evidem Consultores SLBoehringer Ingelheim; Merck Serono International SA; European CommissionUnknown
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Taiwan, Philippines, Australia, Hong Kong, Korea, Republic of, Canada, Italy, Malaysia, United Kingdom, Mexico, Greece, Spain, Netherlands, Switzerland, Israel, Portugal, Germany, Finland, Norway, Romania, Sweden, Serbia and more
-
University of PisaMerck Sharp & Dohme LLCCompleted
-
BiogenCompletedAcute Ischemic StrokeSpain, United States, Germany
-
EMSNot yet recruitingType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCTerminated
-
Garvan Institute of Medical ResearchCompleted
-
Johns Hopkins UniversityMerck Sharp & Dohme LLCTerminatedGlucose HomeostasisUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Royal Adelaide HospitalMerck Sharp & Dohme LLCCompletedDiabetes Mellitus | GastroparesisAustralia
-
Samuel Lunenfeld Research Institute, Mount Sinai...Merck Sharp & Dohme LLCCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Korea, Republic of, Latvia, Peru, Lithuania, Israel, Norway, Finland, Argentina, Austria, Belgium, Germany, Greece, Guatemala, Hungary, India, Italy, Mexico, Poland, Romania, Slovakia, Venezuela
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Singapore
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Germany, United States, France, United Kingdom
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Ono Pharmaceutical Co. LtdCompletedType 2 Diabetes MellitusJapan
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Belgium, Canada, France, India, Italy, Korea, Republic of, Malaysia, Netherlands, Spain
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Novartis PharmaceuticalsWithdrawn
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
University of VermontCompletedImpaired Glucose Tolerance | Pre-diabetes | Impaired Fasting GlucoseUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
Istanbul UniversityNestléCompleted
-
Novartis PharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
University of Southern CaliforniaCompletedInflammation | AtherosclerosisUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Medical College of WisconsinMerck Sharp & Dohme LLCCompletedDiabetes | AtherosclerosisUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Merck Sharp & Dohme LLCCompleted
-
Royal Adelaide HospitalCompletedDiabetes Mellitus | GastroparesisAustralia
-
Merck Sharp & Dohme LLCCompleted
-
Wolfgang-Michael FranzWithdrawn
-
Hvidovre University HospitalUniversity of CopenhagenCompletedSevere ObesityDenmark
-
Dawn Smiley MDCompletedHyperglycemia | Ketosis Prone Diabetes | Diabetes KetoacidosisUnited States
-
Boehringer IngelheimEli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
vTv TherapeuticsCompleted
-
AstraZenecaCompleted
-
Vanderbilt University Medical CenterAmerican Heart AssociationCompleted
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Spain, United Kingdom, United States, France
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2
-
Ludwig-Maximilians - University of MunichMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusGermany
-
University of ArkansasUniversity Hospital, Geneva; Université de MontréalTerminatedHepatic Encephalopathy | Cirrhosis | Refractory Ascites | Hepatic HydrothoraxUnited States, Canada, Switzerland
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus